Back to Search Start Over

Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03)

Authors :
Leleu, Xavier
Karlin, Lionel
Kolb, Brigitte
Tiab, Mourad
Araujo, Carla
Meuleman, Nathalie
De Revel, Thierry
Bourquard, Pascal
Lenain, Pascal
Roussel, Murielle
Jaccard, Arnaud
Petillon, Marie-Odile
Belhadj-Merzoug, Karim
Lepeu, Gerard
Chretien, Marie-Lorraine
Fontan, Jean
Rodon, Philippe
Schmitt, Anna
Offner, Fritz
Voillat, Laurent
Cereja, Sophie
Kuhnowski, Frederique
Rigaudeau, Sophie
Decaux, Olivier
Humbrecht-Kraut, Catherine
Frayfer, Jamile
Fitoussi, Olivier
Roos Weil, Damien
Eisenmann, Jean Claude
Dorvaux, Veronique
Voog, Eric G.
Hulin, Cyrille
Attal, Michel
Moreau, Philippe
Facon, Thierry
Source :
Blood; December 2015, Vol. 126 Issue: 23 p3028-3028, 1p
Publication Year :
2015

Abstract

Leleu: Chugai: Honoraria; LeoPharma: Honoraria; Pierre Fabre: Honoraria; BMS: Honoraria; Novartis: Honoraria; TEVA: Honoraria; Amgen: Honoraria; Takeda: Honoraria; Celgene: Honoraria; Janssen: Honoraria. Karlin:Janssen: Honoraria; BMS: Honoraria; Amgen: Honoraria; Sandoz: Honoraria, Membership on an entity's Board of Directors or advisory committees; Celgene: Honoraria. Fitoussi:Sandoz: Membership on an entity's Board of Directors or advisory committees. Moreau:Bristol-Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees; Janssen-Cilag: Honoraria, Membership on an entity's Board of Directors or advisory committees; Millennium: Honoraria, Membership on an entity's Board of Directors or advisory committees.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
126
Issue :
23
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs53082882
Full Text :
https://doi.org/10.1182/blood.V126.23.3028.3028